Targeting a ceramide double bond improves insulin resistance and hepatic steatosis

Bhagirath Chaurasia, Tippetts TS, Mayoral Monibas R, Jing Liu, Li Y, L Wang, Wilkerson JL, Sweeney Cr, Pereira Rf, DH Sumida,

Yearbook of pediatric endocrinology · 2020 · 11 citations · 0 references

Concepts

Abstract

By genetically engineering mice, the authors deleted the enzyme dihydroceramide desaturase 1 (DES1), which normally inserts a conserved double bond into the backbone of ceramides. Ablation of DES1 from whole animals or tissue-specific deletion in the liver and/or adipose tissue resolved hepatic steatosis and insulin resistance in mice caused by leptin deficiency or obesogenic diets